STOCK TITAN

Kenvue Inc. Stock Price, News & Analysis

KVUE NYSE

Welcome to our dedicated page for Kenvue news (Ticker: KVUE), a resource for investors and traders seeking the latest updates and insights on Kenvue stock.

Kenvue Inc. (KVUE) delivers essential consumer health solutions through trusted brands like Tylenol and Neutrogena. This page serves as a comprehensive repository for official updates and analysis-driven news about the company’s operations in pain management, skincare, oral care, and women’s health.

Investors and professionals will find timely updates on earnings reports, regulatory developments, and strategic partnerships. All content is curated to provide actionable insights while maintaining strict neutrality regarding investment decisions.

The news collection covers key business areas including product innovations backed by R&D expertise, financial performance across global markets, and leadership announcements shaping corporate strategy. Content is verified against primary sources to ensure accuracy.

Bookmark this page to stay informed about Kenvue’s evolving position in the consumer health sector. Regular updates provide clarity on how the company addresses market challenges through its science-first approach and brand portfolio management.

News
Rhea-AI Summary
Kenvue (NYSE: KVUE), known for brands like Tylenol, Neutrogena, and Listerine, has achieved a significant milestone by making its debut on the Fortune 500 list at position 281, with annual sales of $15.5 billion in 2024. As a newly independent company, Kenvue operates in over 165 countries with a workforce of 20,000 employees, reaching approximately 1.2 billion consumers daily through its Essential Health, Self Care, and Skin Health & Beauty brands. CEO Thibaut Mongon highlighted this achievement as validation of the company's dedication and progress toward becoming the global leader in consumer health. The company focuses on combining scientific expertise with human insights and advanced technology to advance its wellness mission.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
none
-
Rhea-AI Summary

Kenvue Inc. (NYSE: KVUE), known for brands like Neutrogena®, Listerine®, Aveeno®, and Tylenol®, has announced its participation in the Deutsche Bank's dbAccess Global Consumer Conference in Paris, France. The company's leadership team, including CEO Thibaut Mongon, CFO Amit Banati, and Group President Carlton Lawson, will engage in a fireside chat on June 3, 2025, at 6:00 a.m. ET / 12:00 p.m. CET. Investors can access a live webcast of the session on investors.kenvue.com, with a replay available after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
none
-
Rhea-AI Summary

Kenvue (NYSE: KVUE) has announced its global Kenvue Cares Week initiative, showcasing significant community engagement across 21 markets on six continents. The company's employees, known as Kenvuers, are contributing over 5,000 volunteer hours and assembling approximately 22,000 hygiene kits containing more than 110,000 products from brands like Neutrogena®, Listerine®, and Johnson's® Baby.

The program, which has seen a fourfold increase in site participation since its inaugural year, involves partnerships with organizations like Save the Children, Heart to Heart International, and various local nonprofits. Activities include disaster relief efforts, environmental initiatives, and community support programs across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific regions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
none
Rhea-AI Summary
Kenvue (NYSE: KVUE) reported its Q1 2025 financial results, showing a 3.9% decrease in net sales and 1.2% decline in organic sales. The company's performance was impacted by foreign currency headwinds of 2.7%. Key financial metrics include: • Gross profit margin increased to 58.0% from 57.6% • Operating income margin rose to 14.9% from 14.1% • Diluted EPS improved to $0.17 from $0.15 • Adjusted diluted EPS decreased to $0.24 from $0.28 For FY2025, Kenvue updated its outlook to reflect foreign exchange rates and tariff impacts, projecting: • Net sales growth of +1% to +3% • Organic sales growth of +2% to +4% • Expected decline in adjusted operating income margin • Adjusted diluted EPS to remain flat year-over-year
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.11%
Tags
-
Rhea-AI Summary

Kenvue (NYSE: KVUE) has appointed Amit Banati as its new Chief Financial Officer, effective May 12, 2025. Banati, a 30-year veteran in consumer products finance and operations, will succeed Paul Ruh and oversee Finance and Strategy functions. Banati joins from Kellanova (previously Kellogg Company) where he served as Vice Chairman and CFO, with prior experience at Kraft Foods, Cadbury Schweppes, and Procter & Gamble.

The new CFO brings significant international operations experience, particularly in Asia Pacific, Middle East, India, and Africa. His focus will be on supporting revenue growth through data management, resource allocation, margin improvement, strengthening cash flow, and fostering greater agility in business planning and financial forecasting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.11%
Tags
none
-
Rhea-AI Summary

Kenvue (NYSE: KVUE), the world's largest pure-play consumer health company by revenue, has scheduled its first quarter 2025 financial results announcement for May 8, 2025, before market open. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results.

Investors can access the conference call by dialing 877-407-8835 (U.S.) or +1 201-689-8779 (international). A live webcast will be available at investors.kenvue.com, with a replay accessible after the event.

Kenvue's portfolio includes renowned brands such as Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena, and Tylenol, which are science-backed and recommended by healthcare professionals globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
News
Rhea-AI Summary

Kenvue (NYSE: KVUE) has announced a quarterly dividend declaration approved by its Board of Directors. The company will pay a dividend of $0.205 per share on its common stock. The dividend will be distributed on May 28, 2025, to shareholders who are recorded on the company's books at the close of business on May 14, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.79%
Tags
dividends
-
Rhea-AI Summary

Kenvue Inc. (NYSE: KVUE), the world's largest pure-play consumer health company, has announced a five-year collaboration with Microsoft to transform its digital operations through advanced AI technologies. The partnership will leverage Microsoft Azure's capabilities in machine-enabled collaboration, predictive analytics, smart agents, digital twins, and generative AI.

The collaboration aims to:

  • Accelerate product development and optimize clinical research data
  • Advance data-driven market strategies and personalize consumer experiences
  • Enhance retail excellence through algorithmic selling and improved inventory management
  • Optimize business processes for new growth opportunities

Kenvue is already piloting Microsoft Azure AI, Microsoft 365 Copilot, and Copilot Studio integration across supply chain, operations, and content creation functions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.79%
Tags
none
-
Rhea-AI Summary

Kenvue Inc. (NYSE: KVUE) has announced actress and entrepreneur Shay Mitchell as the first global brand ambassador for OGX® Haircare. Mitchell will represent the brand's Fixer character in a new 360° campaign promoting the OGX® Bond Protein Repair line.

The campaign features Mitchell alongside Trichologist Abbey Yung, highlighting solutions for hair damage through television spots and a #DamageDetected social media series. The new product line includes a Bond Protein Repair 450°F Heat Protect Spray, formulated with a patented bond-building protein to repair and protect hair at a lower price point than salon brands.

According to Andrew Stanleick, President of Skin Health & Beauty at Kenvue, 8 in 10 people experience hair damage. The campaign aims to address these concerns with science-backed repair solutions. OGX® currently holds the position of #1 in hair repair based on market data through November 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.51%
Tags
none
Rhea-AI Summary

Kenvue Inc. (NYSE: KVUE) has launched the new Neutrogena® Ultra Sheer® Face Liquid Mineral Sunscreen SPF 70, addressing key consumer barriers to daily sunscreen use. According to a December 2024 company study, 99% of healthcare providers believe better application and aesthetic experiences would increase patient sunscreen usage.

The company has partnered with John Cena and dermatologist Dr. Neera Nathan for the 'Sunscreen You Can't See' campaign, leveraging Cena's 'You Can't See Me' catchphrase to highlight the product's invisible finish. The sunscreen features Helioplex® and Purescreen® Technology for broad-spectrum UVA/UVB protection.

Neutrogena® is expanding its sun safety initiatives in 2025 as the official sun care sponsor of Coachella, Stagecoach Festival, and the World Surf League. The brand is also strengthening its partnership with the Melanoma Research Foundation, surpassing $1 million in total donations, and launching the Sun Safety for All educational program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none

FAQ

What is the current stock price of Kenvue (KVUE)?

The current stock price of Kenvue (KVUE) is $21.45 as of June 13, 2025.

What is the market cap of Kenvue (KVUE)?

The market cap of Kenvue (KVUE) is approximately 41.7B.
Kenvue Inc.

NYSE:KVUE

KVUE Rankings

KVUE Stock Data

41.72B
1.92B
0.04%
102.41%
1.97%
Household & Personal Products
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
SUMMIT